Sodium/myo-inositol cotransporter is a protein that in humans is encoded by the SLC5A3 gene.[5][6]
Expression of the myo-inositol transport protein is regulated by osmotic stress.[7]
See also
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000198743 – Ensembl, May 2017
 
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000089774 – Ensembl, May 2017
 
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
 
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
 
- ^ Berry GT, Mallee JJ, Kwon HM, Rim JS, Mulla WR, Muenke M, Spinner NB (Jul 1995). "The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21". Genomics. 25 (2): 507–13. doi:10.1016/0888-7543(95)80052-N. PMID 7789985.
 
- ^ "Entrez Gene: SLC5A3 solute carrier family 5 (inositol transporters), member 3".
 
- ^ Lee SD, Choi SY, Lim SW, Lamitina ST, Ho SN, Go WY, Kwon HM (2011). "TonEBP stimulates multiple cellular pathways for adaptation to hypertonic stress: Organic osmolyte-dependent and -independent pathways". AJP: Renal Physiology. 300 (3): F707 – F715. doi:10.1152/ajprenal.00227.2010. PMC 3064130. PMID 21209002.
 
 
Further reading
- Kwon HM, Yamauchi A, Uchida S, et al. (1992). "Cloning of the cDNa for a Na+/myo-inositol cotransporter, a hypertonicity stress protein". J. Biol. Chem. 267 (9): 6297–301. doi:10.1016/S0021-9258(18)42695-6. PMID 1372904.
 
- Berry GT, Mallee JJ, Blouin JL, Antonarakis SE (1996). "The 21q22.1 STS marker, VN02 (EST00541 cDNA), is part of the 3' sequence of the human Na+/myo-inositol cotransporter (SLC5A3) gene". Cytogenet. Cell Genet. 73 (1–2): 77–8. doi:10.1159/000134311. PMID 8646889.
 
- Mallee JJ, Atta MG, Lorica V, et al. (1998). "The structural organization of the human Na+/myo-inositol cotransporter (SLC5A3) gene and characterization of the promoter". Genomics. 46 (3): 459–65. doi:10.1006/geno.1997.5055. PMID 9441750.
 
- Porcellati F, Hlaing T, Togawa M, et al. (1998). "Human Na(+)-myo-inositol cotransporter gene: alternate splicing generates diverse transcripts". Am. J. Physiol. 274 (5 Pt 1): C1215–25. doi:10.1152/ajpcell.1998.274.5.C1215. PMID 9612208. S2CID 22626824.
 
- Rim JS, Atta MG, Dahl SC, et al. (1998). "Transcription of the Sodium/myo-Inositol Cotransporter Gene Is Regulated by Multiple Tonicity-responsive Enhancers Spread over 50 Kilobase Pairs in the 5′-Flanking Region". J. Biol. Chem. 273 (32): 20615–21. doi:10.1074/jbc.273.32.20615. PMC 2365891. PMID 9685419.
 
- Hattori M, Fujiyama A, Taylor TD, et al. (2000). "The DNA sequence of human chromosome 21". Nature. 405 (6784): 311–9. Bibcode:2000Natur.405..311H. doi:10.1038/35012518. PMID 10830953.
 
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
 
- Suzuki Y, Yamashita R, Shirota M, et al. (2004). "Sequence Comparison of Human and Mouse Genes Reveals a Homologous Block Structure in the Promoter Regions". Genome Res. 14 (9): 1711–8. doi:10.1101/gr.2435604. PMC 515316. PMID 15342556.
 
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.
 
- Thangaraju M, Gopal E, Martin PM, et al. (2007). "SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases". Cancer Res. 66 (24): 11560–4. doi:10.1158/0008-5472.CAN-06-1950. PMID 17178845.
 
 
 | 
|---|
By group  | 
|---|
 SLC1–10  | 
|---|
 | (1): |  | 
|---|
 | (2): |  | 
|---|
 | (3): |  | 
|---|
 | (4): |  | 
|---|
 | (5): |  | 
|---|
 | (6): |  | 
|---|
 | (7): |  | 
|---|
 | (8): |  | 
|---|
 | (9): |  | 
|---|
 | (10): |  | 
|---|
 
  |  
  |  SLC11–20  | 
|---|
 | (11): | 
- proton coupled metal ion transporter
  
  | 
|---|
 | (12): |  | 
|---|
 | (13): | 
- human Na+-sulfate/carboxylate cotransporter
  
  | 
|---|
 | (14): |  | 
|---|
 | (15): | 
- proton oligopeptide cotransporter
  
  | 
|---|
 | (16): | 
- monocarboxylate transporter
  
  | 
|---|
 | (17): |  | 
|---|
 | (18): |  | 
|---|
 | (19): |  | 
|---|
 | (20): |  | 
|---|
 
  |  
  |  SLC21–30  | 
|---|
 | (21): |  | 
|---|
 | (22): |  | 
|---|
 | (23): | 
- Na+-dependent ascorbic acid transporter
  
  | 
|---|
 | (24): |  | 
|---|
 | (25): |  | 
|---|
 | (26): | 
- multifunctional anion exchanger
  
  | 
|---|
 | (27): |  | 
|---|
 | (28): | 
- Na+-coupled nucleoside transport (SLC28A1
  
  | 
|---|
 | (29): | 
- facilitative nucleoside transporter
  
  | 
|---|
 | (30): |  | 
|---|
 
  |  
  |  SLC31–40  | 
|---|
 | (31): |  | 
|---|
 | (32): |  | 
|---|
 | (33): |  | 
|---|
 | (34): | 
- type II Na+-phosphate cotransporter
  
  | 
|---|
 | (35): | 
- nucleoside-sugar transporter
 
- 
 
- 
 
- 
 
- 
- SLC35E1
 
- SLC35E2
 
- SLC35E3
 
- SLC35E4
 
   
  | 
|---|
 | (36): |  | 
|---|
 | (37): | 
- sugar-phosphate/phosphate exchanger
  
  | 
|---|
 | (38): | 
- System A & N, sodium-coupled neutral amino-acid transporter
  
  | 
|---|
 | (39): |  | 
|---|
 | (40): | 
- basolateral iron transporter
  
  | 
|---|
 
  |  
  |  SLC41–48  | 
|---|
 | (41): |  | 
|---|
 | (42): |  | 
|---|
 | (43): | 
- Na+-independent, system-L like amino-acid transporter
  
  | 
|---|
 | (44): |  | 
|---|
 | (45): | 
- Putative sugar transporter
  
  | 
|---|
 | (46): |  | 
|---|
 | (47): |  | 
|---|
 | (48): |  | 
|---|
 
  |  
  |   |  
  |  
  | 
 | 
see also solute carrier disorders  |